¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀå
Cardiovascular Surgery Devices
»óǰÄÚµå : 1760848
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 30¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 24¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 3.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 30¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °ü·ù ÀÏȸ¿ëǰÀº CAGR 3.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 21¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù. Beating Heart Surgery ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 5,020¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR5.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀåÀº 2024³â¿¡ 6¾ï 5,020¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 240¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 5.6%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.2%¿Í 3.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.6%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀåÀ» Çü¼ºÇÏ´Â Çõ½ÅÀº ¹«¾ùÀΰ¡?

½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀåÀº ÀÇ·á ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú Çõ½ÅÀûÀÎ ¼ö¼úÀû Á¢±ÙÀ¸·Î ÀÎÇØ º¯È­ÀÇ ½Ã±â¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú ÀåºñºÎÅÍ ·Îº¿ º¸Á¶ ½Ã½ºÅÛ±îÁö ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â Àåºñ·ÎÀÇ ÀüȯÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. °æÇÇÀû ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú(TAVR)°ú °æÇÇÀû °ü»óµ¿¸Æ ÁßÀç¼ú(PCI) ½Ã½ºÅÛ°ú °°Àº ±â±âÀÇ µîÀåÀº Ä¡·áÀÇ Àü¸ÁÀ» ÀçÁ¤ÀÇÇϰí ÀüÅëÀûÀÎ °³½É¼úÀÇ Çʿ伺À» ÃÖ¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú Àåºñ¿¡ AI¿Í ¸Ó½Å·¯´×À» ÅëÇÕÇÏ¿© Á¤È®µµ¸¦ Çâ»ó½ÃÄÑ ½Ã¼ú ¼º°ø·üÀ» ³ôÀ̰í ÇÕº´Áõ À§ÇèÀ» ³·Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Ç¥ÁØ Ä¡·á¹ýÀ» °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó Àü ¼¼°è ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÇ Ã¤Å÷üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼¼°èÀûÀ¸·Î »ç¸Á·üÀÇ ÁÖ¿ä ¿øÀÎÀÎ ½ÉÇ÷°ü Áúȯ(CVDs)ÀÌ ±ÞÁõÇÔ¿¡ µû¶ó ½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÁÂ½Ä »ýȰ½À°ü, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü, ºñ¸¸À² Áõ°¡´Â ½ÉÀ庴ÀÇ È®»êÀ» ÃËÁøÇϰí È¿°úÀûÀÎ ¼ö¼úÀû °³ÀÔÀÇ Çʿ伺À» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç ÀϺΠÁö¿ª¿¡¼­´Â °í·ÉÈ­ ¹× CVDÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´õ ¸¹Àº ¼ö¼úÀÌ ÇÊ¿äÇϸç, ÀÌ¿¡ µû¶ó ´õ Á¤±³ÇÑ ¼ö¼ú Àåºñ°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. º´¿ø°ú ¼ö¼ú¼¾ÅÍ´Â Áõ°¡Çϴ ȯÀÚ À¯ÀÔ¿¡ ´ëÀÀÇÏ°í ¿ì¼öÇÑ ÀÓ»ó °á°ú¸¦ º¸ÀåÇϱâ À§ÇØ ±â¼úÀûÀ¸·Î Áøº¸µÈ Àåºñ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±Þ°ÝÇÑ ¼ºÀåÀº Çö´ë ¼ö¼ú ±â¹ýÀÇ À¯¿ë¼º°ú ÀÌÁ¡¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú »óȯÀÌ ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

±ÔÁ¦ »óȲ°ú »óȯ Á¤Ã¥Àº ½ÃÀå »óȲÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼­´Â ¾ö°ÝÇÑ ±ÔÁ¦°¡ Á¸ÀçÇϱ⠶§¹®¿¡ ±â¾÷µéÀº ¾ÈÀü¼º°ú À¯È¿¼º ±âÁØÀ» ÃæÁ·ÇÏ´Â Á¦Ç°À» Çõ½ÅÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇØ¾ß¸¸ ÇÕ´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À̳ª À¯·´ÀǾàǰû(EMA)°ú °°Àº ±â°üÀÇ ½ÂÀÎ ÀýÂ÷´Â ¸ðµç »õ·Î¿î ±â±â ½ÃÀå ÁøÀÔ°ú ¼ö¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ÀÌÁ¤Ç¥ÀÔ´Ï´Ù. ÇÑÆí, ¹Ì±¹, µ¶ÀÏ, ÀϺ»°ú °°Àº ±¹°¡µéÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥Àº ÷´Ü ½ÉÇ÷°ü ¼ö¼ú¿¡ ´ëÇÑ È¯ÀÚ Á¢±Ù¼ºÀ» ³ô¿© ÀÇ·á ±â°üÀÌ ¼ö¼ú Àåºñ¸¦ ¾÷±×·¹À̵åÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÀüüÀûÀ¸·Î ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ÁÖ¿ä ½ÃÀå ±â¾÷µé¿¡°Ô ±âȸ¿Í µµÀüÀ» ¸ðµÎ Á¦°øÇÕ´Ï´Ù.

½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀº?

½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ý·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÅëÁõ °¨¼Ò¿Í ºü¸¥ ȸº¹À» ¿øÇϴ ȯÀÚµéÀÇ ¼±È£·Î ÀÎÇØ ÃÖ¼Ò Ä§½À ¼ö¼ú·ÎÀÇ ÀüȯÀÌ ½ÃÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó °³¼±°ú ÀÇ·áºñ Áõ°¡´Â ÷´Ü ¼ö¼ú ÀåºñÀÇ Ã¤ÅÃÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ÀüÅëÀûÀÎ ¼ö¼ú°ú ÃÖ¼Ò Ä§½À ¼ö¼úÀ» °áÇÕÇÑ ÇÏÀ̺긮µå ¼ö¼ú½Ç Áõ°¡ Ãß¼¼µµ ÷´Ü ¼ö¼ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀ» °³¼±Çϱâ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡¿Í ¹Î°£ ±â¾÷ÀÇ ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ½ÃÀå È®´ë¸¦ °­·ÂÇÏ°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ä¼ÒµéÀÌ Á¾ÇÕÀûÀÎ ¼ºÀå ÇÁ·¹ÀÓ¿öÅ©¸¦ Çü¼ºÇÏ¿© ½ÉÀåÇ÷°ü ¿Ü°ú¿ë ±â±â ½ÃÀåÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù.

ºÎ¹®

µð¹ÙÀ̽º À¯Çü(°ü·ù ÀÏȸ¿ë, ½ÉÀå ¼ö¼ú ½Ã½ºÅÛ, ½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ, ½ÉÀå ÀýÁ¦ µð¹ÙÀ̽º), ¿ëµµ(½ÉÀå ºÎÁ¤¸Æ, °ü»óµ¿¸Æ Áúȯ, ¿ïÇ÷¼º ½ÉºÎÀü, ¼±Ãµ¼º ½ÉÁúȯ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 46°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiovascular Surgery Devices Market to Reach US$3.0 Billion by 2030

The global market for Cardiovascular Surgery Devices estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Perfusion Disposables, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Beating Heart Surgery Systems segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$650.2 Million While China is Forecast to Grow at 5.6% CAGR

The Cardiovascular Surgery Devices market in the U.S. is estimated at US$650.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$602.4 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Cardiovascular Surgery Devices Market - Key Trends & Drivers Summarized

What Innovations Are Shaping the Cardiovascular Surgery Devices Market?

The cardiovascular surgery devices market is undergoing a transformative phase characterized by rapid advancements in medical technology and innovative surgical approaches. From minimally invasive surgical devices to robotic-assisted systems, there is a significant shift towards equipment that reduces recovery times and improves patient outcomes. The advent of devices like transcatheter aortic valve replacement (TAVR) and percutaneous coronary intervention (PCI) systems has redefined the treatment landscape, minimizing the need for traditional open-heart surgeries. Moreover, the integration of AI and machine learning in surgery devices is enhancing precision, leading to better procedural success rates and lower complication risks. These advancements are not only elevating the standard of care but also increasing the adoption rate among healthcare providers worldwide.

Why Is There a Rising Demand for Cardiovascular Surgery Devices?

The demand for cardiovascular surgery devices is escalating, driven by a surge in cardiovascular diseases (CVDs) globally, which remain a leading cause of mortality. Sedentary lifestyles, unhealthy diets, and rising obesity rates are contributing to the prevalence of heart diseases, thereby increasing the need for effective surgical interventions. Additionally, aging populations in regions such as North America, Europe, and parts of Asia-Pacific are adding to the burden of CVDs, necessitating more surgeries and hence more advanced surgical devices. Hospitals and surgical centers are increasingly investing in technologically advanced devices to meet the growing patient inflow and ensure superior clinical outcomes. This surge is further bolstered by an increasing awareness among the public about the availability and benefits of modern surgical techniques, pushing the market growth even further.

How Are Regulatory Approvals and Reimbursements Impacting the Market?

Regulatory landscapes and reimbursement policies play a pivotal role in shaping the cardiovascular surgery devices market. With stringent regulations in place, particularly in developed economies, companies are compelled to invest heavily in research and development to innovate products that meet safety and efficacy standards. The approval processes by agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are crucial milestones for any new device, influencing their market entry and acceptance. On the other hand, favorable reimbursement policies in countries like the U.S., Germany, and Japan are making advanced cardiovascular surgeries more accessible to patients, thereby encouraging healthcare facilities to upgrade their surgical equipment. These factors collectively influence the overall dynamics, offering both opportunities and challenges for key market players.

What Are the Drivers Behind the Market Growth for Cardiovascular Surgery Devices?

The growth in the cardiovascular surgery devices market is driven by several factors, including technological advancements, an aging global population, and an increasing incidence of cardiovascular diseases. The shift towards minimally invasive surgeries, driven by patient preference for reduced pain and quicker recovery, is significantly bolstering the market. Enhanced healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure, is enabling the adoption of advanced surgical devices. The rising trend of hybrid operating rooms, which combine traditional and minimally invasive surgeries, is another catalyst, creating demand for sophisticated surgical devices. Furthermore, increasing government initiatives to improve healthcare access and growing investments in healthcare technologies by private players are providing strong support to market expansion. Together, these elements form a comprehensive growth framework, propelling the cardiovascular surgery devices market forward.

SCOPE OF STUDY:

The report analyzes the Cardiovascular Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Perfusion Disposables, Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices); Application (Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Congenital Heart Defects, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â